Bereavement Support Strategies for Grief After Child Loss
Trial Summary
What is the purpose of this trial?
Parents of children who die traumatically or unexpectedly from things like suicide or an overdose suffer from mental and physical health problems and can experience massive disruptions in their family life. For about half of these parents, the first, and sometimes only, interactions they have with the healthcare system when their child dies are with a medical examiner or coroner (hereafter 'ME'). But MEs have little to no training in helping grieving families, and there are no standards guiding medical examiners or coroners on how or even if they should help grieving families. This gap leaves parents to find the help they need on their own. This research will test two different strategies for addressing this gap in the healthcare system.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment CommunityRx-Bereavement and related bereavement support strategies for grief after child loss?
Research indicates that bereavement support, including counseling and support groups, can help reduce anxiety and feelings of isolation after losing a loved one. These interventions promote communication and healing within families, which can be beneficial for those grieving the loss of a child.12345
How does this bereavement support treatment differ from other treatments for grief after child loss?
This treatment is unique because it focuses on providing structured bereavement support specifically for parents who have lost a child, using a preventive model of care that includes education, guidance, and support. Unlike other general grief interventions, it targets highly distressed parents and aims to reduce psychological symptoms and marital dysfunction, offering a more tailored approach to their specific needs.26789
Research Team
Stacy Lindau, MD, MAPP
Principal Investigator
University of Chicago
Kelly Michelson, MD, MPH
Principal Investigator
Lurie Children's Hospital
Eligibility Criteria
This trial is for parents or legal caregivers who have lost a child under 25 years old to unexpected or traumatic events, and are referred by medical examiners. Participants must be able to communicate in English or Spanish and give permission to the ME for referral. Those unable to understand these languages or under 18 cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either CommunityRx-Bereavement (CRx-B) or General Bereavement Support Information (GBSI) to support parents after a child's unexpected or traumatic death
Follow-up
Participants are monitored for self-efficacy in finding resources and symptoms of complicated grief
Treatment Details
Interventions
- CommunityRx-Bereavement
- General Bereavement Support Information
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ann & Robert H Lurie Children's Hospital of Chicago
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator
University of Chicago
Collaborator
Missing Pieces, a program of the HAP Foundation
Collaborator